Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:INTT NASDAQ:NAUT NASDAQ:RPID NASDAQ:SENS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINTTinTEST$18.80$17.12$6.63▼$20.00$236.22M1.5217,637 shs206,816 shsNAUTNautilus Biotechnology$2.28$2.63$0.62▼$4.31$289.74M0.75396,128 shs475,526 shsRPIDRapid Micro Biosystems$1.71$2.13$1.66▼$4.94$78.95M1.45128,943 shs118,657 shsSENSSenseonics Holdings, Inc. Common Stock$6.74$6.52$4.79▼$12.58$281.75M1.04551,628 shs1.15 million shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINTTinTEST0.00%+8.05%+7.43%+34.00%+168.96%NAUTNautilus Biotechnology0.00%+1.79%-10.24%-24.75%+222.03%RPIDRapid Micro Biosystems0.00%-2.84%-17.39%-27.23%-45.37%SENSSenseonics Holdings, Inc. Common Stock0.00%-6.13%+9.42%+4.01%+673,999,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINTTinTEST$18.80$17.12$6.63▼$20.00$236.22M1.5217,637 shs206,816 shsNAUTNautilus Biotechnology$2.28$2.63$0.62▼$4.31$289.74M0.75396,128 shs475,526 shsRPIDRapid Micro Biosystems$1.71$2.13$1.66▼$4.94$78.95M1.45128,943 shs118,657 shsSENSSenseonics Holdings, Inc. Common Stock$6.74$6.52$4.79▼$12.58$281.75M1.04551,628 shs1.15 million shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINTTinTEST0.00%+8.05%+7.43%+34.00%+168.96%NAUTNautilus Biotechnology0.00%+1.79%-10.24%-24.75%+222.03%RPIDRapid Micro Biosystems0.00%-2.84%-17.39%-27.23%-45.37%SENSSenseonics Holdings, Inc. Common Stock0.00%-6.13%+9.42%+4.01%+673,999,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceINTTinTEST 2.50Moderate Buy$19.001.06% UpsideNAUTNautilus Biotechnology 2.00Hold$4.0075.44% UpsideRPIDRapid Micro Biosystems 2.33Hold$6.00250.88% UpsideSENSSenseonics Holdings, Inc. Common Stock 2.67Moderate Buy$17.00152.23% UpsideCurrent Analyst Ratings BreakdownLatest RPID, SENS, NAUT, and INTT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/3/2026INTTinTEST Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold5/29/2026RPIDRapid Micro Biosystems KeyCorpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$8.00 ➝ $5.005/28/2026SENSSenseonics Holdings, Inc. Common Stock Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/22/2026RPIDRapid Micro Biosystems Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$8.00 ➝ $7.005/12/2026SENSSenseonics Holdings, Inc. Common Stock HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$18.50 ➝ $14.005/11/2026SENSSenseonics Holdings, Inc. Common Stock Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$9.00 ➝ $8.005/5/2026INTTinTEST Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy4/21/2026NAUTNautilus Biotechnology Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/21/2026RPIDRapid Micro Biosystems Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)(Data available from 6/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookINTTinTEST$121.07M1.95$3.27 per share5.75$7.92 per share2.37NAUTNautilus BiotechnologyN/AN/AN/AN/A$1.24 per shareN/ARPIDRapid Micro Biosystems$34.38M2.30N/AN/A$0.75 per share2.28SENSSenseonics Holdings, Inc. Common Stock$35.26M7.99N/AN/A$1.49 per share4.52Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateINTTinTEST$9.34M$0.0481.7447.00N/A2.33%5.31%3.42%N/ANAUTNautilus Biotechnology-$59M-$0.46N/AN/AN/AN/A-35.04%-29.16%8/4/2026 (Estimated)RPIDRapid Micro Biosystems-$47.12M-$1.12N/AN/AN/A-145.81%-131.52%-67.48%7/31/2026 (Estimated)SENSSenseonics Holdings, Inc. Common Stock-$69.11M-$2.00N/AN/AN/A-213.87%-129.97%-67.14%N/ALatest RPID, SENS, NAUT, and INTT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q1 2026RPIDRapid Micro Biosystems-$0.25-$0.31-$0.06-$0.31$7.60 million$8.00 million5/7/2026Q1 2026SENSSenseonics Holdings, Inc. Common Stock-$0.65-$0.71-$0.06-$0.71N/A$11.71 million4/28/2026Q1 2026NAUTNautilus Biotechnology-$0.1450-$0.12+$0.0250-$0.12$0.25 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthINTTinTESTN/AN/AN/AN/AN/ANAUTNautilus BiotechnologyN/AN/AN/AN/AN/ARPIDRapid Micro BiosystemsN/AN/AN/AN/AN/ASENSSenseonics Holdings, Inc. Common StockN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioINTTinTEST0.082.261.38NAUTNautilus BiotechnologyN/A11.8511.85RPIDRapid Micro Biosystems0.932.571.66SENSSenseonics Holdings, Inc. Common Stock1.053.513.19Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipINTTinTEST63.18%NAUTNautilus Biotechnology50.71%RPIDRapid Micro Biosystems52.60%SENSSenseonics Holdings, Inc. Common Stock12.36%Insider OwnershipCompanyInsider OwnershipINTTinTEST5.20%NAUTNautilus Biotechnology41.10%RPIDRapid Micro Biosystems12.70%SENSSenseonics Holdings, Inc. Common Stock4.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableINTTinTEST32012.57 million11.69 millionOptionableNAUTNautilus Biotechnology130127.08 million74.85 millionOptionableRPIDRapid Micro Biosystems20046.17 million40.31 millionNot OptionableSENSSenseonics Holdings, Inc. Common Stock9041.80 million39.84 millionN/ARPID, SENS, NAUT, and INTT HeadlinesRecent News About These CompaniesGMT Capital Corp Lowers Stock Position in Senseonics Holdings, Inc. Common Stock $SENSJune 14, 2026 | marketbeat.comSenseonics Expands Eversense 365 Ecosystem With Welldoc PartnershipJune 11, 2026 | zacks.comReal-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop SystemsJune 6, 2026 | globenewswire.comSenseonics Holdings, Inc. (SENS) Shareholder/Analyst Call TranscriptJune 6, 2026 | seekingalpha.comSenseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026June 1, 2026 | globenewswire.comSenseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Given Consensus Rating of "Moderate Buy" by AnalystsMay 29, 2026 | marketbeat.comSenseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Director Douglas Roeder Purchases 22,686 SharesMay 14, 2026 | insidertrades.comSenseonics Holdings, Inc. (NASDAQ:SENS) Q1 2026 Earnings Call TranscriptMay 10, 2026 | insidermonkey.comSenseonics Holdings, Inc. (SENS) Q1 2026 Earnings Call TranscriptMay 8, 2026 | seekingalpha.comSenseonics Holdings (SENS) Reports Q1 Loss, Beats Revenue EstimatesMay 7, 2026 | zacks.comSenseonics Holdings, Inc. Reports First Quarter 2026 Financial ResultsMay 7, 2026 | globenewswire.comSenseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesMay 5, 2026 | markets.businessinsider.comSenseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters' Option to Purchase Additional SharesMay 4, 2026 | globenewswire.comSenseonics Enters Into Amended Loan Agreement with Hercules to Increase Borrowing Capacity to $140 MillionMay 4, 2026 | globenewswire.comSenseonics shares sink Friday: What's driving the move?May 1, 2026 | msn.comSenseonics Holdings, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call for May 7, 2026 at 4:30 P.M. Eastern TimeMay 1, 2026 | globenewswire.comSenseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded WarrantsApril 30, 2026 | globenewswire.comSenseonics Announces Commencement of $80 Million Public Offering of Common Stock and Pre-Funded WarrantsApril 30, 2026 | globenewswire.comSENS Launches Eversense 365, World's Only One-Year CGM in EuropeApril 27, 2026 | zacks.comSenseonics Announces European Launch of Eversense® 365, The World's First and Only One Year CGM SystemApril 24, 2026 | globenewswire.comSenseonics Reports Strong One-Year Real-World Data for Eversense 365March 17, 2026 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 20265 Stocks Winning the AI Race While Everyone Watches NVIDIABy Bridget Bennett | May 26, 2026The Smart Glasses Gold Rush Is Leaving Old-School Eyewear BehindBy Jeffrey Neal Johnson | May 24, 20265 Under-the-Radar AI Stocks to Watch in JuneBy Thomas Hughes | May 31, 2026AST SpaceMobile Announces Launch Date for Its Next 3 BlueBird SatellitesBy Jessica Mitacek | June 16, 2026RPID, SENS, NAUT, and INTT Company DescriptionsinTEST NYSE:INTT$18.80 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$18.90 +0.09 (+0.51%) As of 06/18/2026 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies. The Electronic Test segment offers in2, Cobal, and LS series manipulators that hold various test heads and enable an operator to reposition a test head for alternate use with various probers or handlers on a test floor; and docking hardware products, which protect the interface contacts and ensure proper repeatable and precise alignment between the test head's interface board and the prober's probing assembly. This segment also provides tester interfaces that offer electrical connections between the tester and the wafer prober or IC handler; scorpion flying probe test systems that designs and manufactures robotics-based electronic test equipment; and BRiZ automated test and programming services. Its products are used in production testing of wafers and specialized packaged ICs in back-end testing by semiconductor manufacturers. The Environmental Technologies segment provides ThermoStream products that are used in the semi market as a stand-alone temperature management tool, or in various electronic test applications; thermal chambers; thermal platforms; Thermonics temperature conditioning products that offer tempered gas or fluid; and ultra-cold storage solutions, including biomedical freezers, refrigerators, and mobile storage solutions. The Process Technologies segment offers EKOHEAT and EASYHEAT induction heating systems; and digital streaming and image capturing solutions. The company markets and sells its products to semiconductor manufacturers, third-party foundries, test and assembly providers, and original equipment manufacturers. inTEST Corporation was incorporated in 1981 and is headquartered in Mount Laurel, New Jersey.Nautilus Biotechnology NASDAQ:NAUT$2.28 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$2.22 -0.05 (-2.41%) As of 06/18/2026 06:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.Rapid Micro Biosystems NASDAQ:RPID$1.71 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$1.75 +0.04 (+2.28%) As of 06/18/2026 07:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.Senseonics Holdings, Inc. Common Stock NASDAQ:SENS$6.74 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$6.52 -0.22 (-3.19%) As of 06/18/2026 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/15 - 06/19 Applied Materials Stock Looks Pricey—Can AI Demand Justify the Rally? Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself? Why Kroger’s Pullback Could Be a Gift for Patient Investors Credo Technologies Accelerates AI—Its Stock Price Will Follow Why Rocket Lab’s Nasdaq-100 Moment Could Change the Story Why Palantir’s Google Cloud Deal Could Change the Debate Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.